TY - JOUR
T1 - Factors associated with successful referral for clinical care of drug users with chronic hepatitis C who have or are at risk for HIV infection
AU - Fishbein, Dawn A.
AU - Lo, Yungtai
AU - Reinus, John F.
AU - Gourevitch, Marc N.
AU - Klein, Robert S.
PY - 2004/11/1
Y1 - 2004/11/1
N2 - The objective of this study was to determine outcomes of referring drug users (DUs) with chronic hepatitis C for clinical evaluation and care. Two hundred twenty-eight persons with detectable hepatitis C virus RNA were given expedited referrals for evaluation and possible treatment of hepatitis C from a prospective study cohort of current and former opiate-addicted DUs. Four outcomes were analyzed: accepted referral, arrived for clinical evaluation, had liver biopsy, and received treatment. One hundred twenty-seven participants (56%) accepted referral, of whom 54 (43%) arrived for evaluation. Of these participants, 12 (22%) had liver biopsy, and 4 (7%) were treated. Multivariate logistic regression revealed that HIV-infected DUs were significantly less likely to accept referral (adjusted odds ratio [ORadj], 0.51; 95% confidence interval [CI], 0.30-0.88), and older participants were more likely to keep an appointment (ORadj, 1.06/y; 95% CI, 1.00-1.12). Of HIV-seropositive participants, those with a history of injection were more likely to accept referral (ORadj, 3.60; 95% CI, 1.08-11.96), and those with higher HIV load (ORadj, 0.50/log10; 95% CI, 0.26-0.94) and Hispanic ethnicity (ORadj, 0.26; 95% CI, 0.07-0.89) were less likely to keep an appointment. Despite expedited referrals for hepatitis C care, only a few participants received an evaluation, and even far fewer were treated. Because increasingly effective treatment is available, better methods are urgently needed to improve evaluation and treatment of HCV-infected DUs, including those coinfected with HIV.
AB - The objective of this study was to determine outcomes of referring drug users (DUs) with chronic hepatitis C for clinical evaluation and care. Two hundred twenty-eight persons with detectable hepatitis C virus RNA were given expedited referrals for evaluation and possible treatment of hepatitis C from a prospective study cohort of current and former opiate-addicted DUs. Four outcomes were analyzed: accepted referral, arrived for clinical evaluation, had liver biopsy, and received treatment. One hundred twenty-seven participants (56%) accepted referral, of whom 54 (43%) arrived for evaluation. Of these participants, 12 (22%) had liver biopsy, and 4 (7%) were treated. Multivariate logistic regression revealed that HIV-infected DUs were significantly less likely to accept referral (adjusted odds ratio [ORadj], 0.51; 95% confidence interval [CI], 0.30-0.88), and older participants were more likely to keep an appointment (ORadj, 1.06/y; 95% CI, 1.00-1.12). Of HIV-seropositive participants, those with a history of injection were more likely to accept referral (ORadj, 3.60; 95% CI, 1.08-11.96), and those with higher HIV load (ORadj, 0.50/log10; 95% CI, 0.26-0.94) and Hispanic ethnicity (ORadj, 0.26; 95% CI, 0.07-0.89) were less likely to keep an appointment. Despite expedited referrals for hepatitis C care, only a few participants received an evaluation, and even far fewer were treated. Because increasingly effective treatment is available, better methods are urgently needed to improve evaluation and treatment of HCV-infected DUs, including those coinfected with HIV.
KW - Drug users
KW - HIV
KW - HIV/hepatitis C virus (HCV) coinfection
KW - Hepatitis C
KW - Treatment referral
UR - http://www.scopus.com/inward/record.url?scp=7244223323&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=7244223323&partnerID=8YFLogxK
U2 - 10.1097/01.qai.0000131932.21612.49
DO - 10.1097/01.qai.0000131932.21612.49
M3 - Article
C2 - 15483466
AN - SCOPUS:7244223323
SN - 1525-4135
VL - 37
SP - 1367
EP - 1375
JO - Journal of Acquired Immune Deficiency Syndromes
JF - Journal of Acquired Immune Deficiency Syndromes
IS - 3
ER -